• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    VIVUS Inc. (VVUS)

    -NasdaqGS
    2.61 Down 0.08(2.97%) Feb 27, 4:00PM EST
    |After Hours : 2.61 0.00 (0.00%) Feb 27, 5:00PM EST
    Add to Portfolio
    Prev Close:2.69
    Open:2.67
    Bid:N/A
    Ask:2.65 x 3300
    1y Target Est:3.63
    Beta:1.1
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:2.54 - 2.68
    52wk Range:2.41 - 6.40
    Volume:2,466,013
    Avg Vol (3m):2,102,960
    Market Cap:271.13M
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for VVUS

    Comparison

    Symbol% ChgMkt Cap
    VVUSDown 2.97%271.13M
    LLYUp 0.20%74.42B
    GSKDown 0.88%114.07B
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.14
    Quarterly EPS Est (Mar-15) :-0.23
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):-0.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback